Sutro Biopharma (STRO) Operating Margin Growth (1y) (2018 - 2025)

Sutro Biopharma (STRO) Operating Margin Growth (1y) (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,552.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,536.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -170.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1,049.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Sutro Biopharma 202.59 Mn 61.16 Mn - -13,584.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -13,584.00
Sep 30, 2025 29,723.00
Jun 30, 2025 18,414.00
Mar 31, 2025 4,127.00
Dec 31, 2024 -47,861.00
Sep 30, 2024 -53,710.00
Jun 30, 2024 25,413.00
Mar 31, 2024 -10,179.00
Dec 31, 2023 60,817.00
Sep 30, 2023 -17,572.00
Jun 30, 2023 -37,454.00
Mar 31, 2023 33,033.00
Dec 31, 2022 -24,137.00
Sep 30, 2022 32,277.00
Jun 30, 2022 -3,402.00
Mar 31, 2022 -53,393.00
Dec 31, 2021 -2,874.00
Sep 30, 2021 -34,755.00
Jun 30, 2021 13,842.00
Mar 31, 2021 13,851.00